PPP1R3B Suppresses Atherosclerosis by Promoting the M2 Polarization of Macrophages Through Glycogen Metabolic Reprogramming
Advanced Science · 2025-11 · 12 (41)
DOI: 10.1002/advs.202506345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 23.09.2025. Verfasst von Lin Shen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biote…. Hauptthemen laut MEDLINE: Macrophages, Atherosclerosis, Glycogen, Protein Phosphatase 1. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, Natural Science Foundation of Zhejiang Province, Medical Science and Technology Project of Zhejiang Province.
Abstract (Originalsprache)
Identifying targets that promote M2 macrophage polarization in the hypoxic plaque microenvironment is crucial for modulating immune metabolism and optimizing energy dynamics in atherosclerotic cardiovascular disease (ASCVD) treatment. The high phagocytic activity of M2 macrophages reduces foam cell formation. Their secretion of anti‐inflammatory cytokines enhances plaque stability, mitigating atherosclerosis progression. Through high‐throughput sequencing and multi‐omics bioinformatics analysis, protein phosphatase 1 regulatory subunit 3B ( PPP1R3B ) is identified as a key regulator linking glycogen metabolism to macrophage polarization. The integrated approach combined transcriptomic analysis of human atherosclerotic plaques (GSE57614) with RNA‐seq of PPP1R3B ‐modulated macrophages, revealing its dual role. PPP1R3B induces anti‐inflammatory M2 macrophage polarization and maintains energy supply in plaques. Its absence accelerates plaque progression. PPP1R3B regulates M2 macrophage polarization and energy metabolism via phosphorylated STAT3 (p‐STAT3), which plays a dual role by activating anti‐inflammatory transcriptional programs through the PPAR‐γ/PGC‐1α/CD206 axis in the nucleus and enhancing glycogenolysis‐mediated metabolic activity via the p‐GSK‐3β/p‐PYGL/p‐GYS2 axis in mitochondria. STAT3 plays a dual role in metabolic regulation and macrophage phenotype modulation. By orchestrating glycogen metabolic reprogramming, PPP1R3B ‐induced M2 polarization presents a novel strategy for anti‐ASCVD drug development, with significant potential for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, Key Laboratory of Precision Medicine of Lishui City, The Fif…
- Clinical College of The Affiliated Central Hospital, School of Medicine, Lishui University, Lishui, 323000, China.
- Department of Radiology, Lishui Hospital of Zhejiang University, School of Medicine, Lishui, 323000, China.
- Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, S…
- Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.
- Theranostics Center of Excellence (TCE), Yong Loo Lin School of Medicine, National University of Singapore, 11 Biopolis Way, Helios, Singapore, 138667, Singapore.
ORCID-Profile: Jianhua Zou
Förderung
- China Postdoctoral Science Foundation
- Natural Science Foundation of Zhejiang Province
- Medical Science and Technology Project of Zhejiang Province
- National Natural Science Foundation of China
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Key R&D Program of Lishui
- Exploration Project of Zhejiang Natural Science Foundation
- National University of Singapore
Zitieren
APA
Shen, L., Yu, J., Chen, W., Bi, Y., Yang, Z., Lu, C., Jiang, C., Yang, Y., Chen, M., Zou, J., Lv, L., Chen, X., & Ji, J. (2025). PPP1R3B Suppresses Atherosclerosis by Promoting the M2 Polarization of Macrophages Through Glycogen Metabolic Reprogramming. Advanced Science, 12(41). https://doi.org/10.1002/advs.202506345
Vancouver
Shen L, Yu J, Chen W, Bi Y, Yang Z, Lu C, et al. PPP1R3B Suppresses Atherosclerosis by Promoting the M2 Polarization of Macrophages Through Glycogen Metabolic Reprogramming. Advanced Science. 2025;12(41). doi:10.1002/advs.202506345
BibTeX
@article{Shen2025,
author = {Shen, Lin and Yu, Junchao and Chen, Weiqian and Bi, Yanran and Yang, Zhangyu and Lu, Chenying and Jiang, Chengli and Yang, Yang and Chen, Minjiang and Zou, Jianhua and Lv, Lingchun and Chen, Xiaoyuan and Ji, Jiansong},
title = {PPP1R3B Suppresses Atherosclerosis by Promoting the M2 Polarization of Macrophages Through Glycogen Metabolic Reprogramming},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {41},
doi = {10.1002/advs.202506345}
}
EUVIMED